COVID-19 vaccine distribution would begin within 24 hours after approval

(HealthDay)—Distribution of a COVID-19 vaccine in the United States would begin within 24 hours of its approval or emergency use authorization, and the plan is that no American will have to “pay a single dime” out of their own pocket for the vaccine, federal officials said Thursday. The officials with Operation Warp Speed—the multiagency effort to get a COVID-19 vaccine […]

Read more

Research raises questions about how eager people will be to receive COVID-19 vaccine

New research shows consumers strongly prefer “natural,” not synthetic, products to prevent ailments. That presents a dilemma. Medical researchers are racing to develop a vaccine for COVID-19. When they do, how receptive will consumers be? “Vaccines are technically a treatment to prevent an ailment,” said Sydney Scott, assistant professor of marketing at Olin Business School at Washington University in St. […]

Read more

US bets on small, untested company to deliver COVID vaccine

When precious vats of COVID-19 vaccine are finally ready, jabbing the lifesaving solution into the arms of Americans will require hundreds of millions of injections. As part of its strategy to administer the vaccine as quickly as possible, the Trump administration has agreed to invest more than half a billion in tax dollars in ApiJect Systems America, a young company […]

Read more

Russia starts clinical trials of COVID-19 vaccine

Clinical trials of a Russian coronavirus vaccine have started Wednesday, the Health Ministry said in a statement. Two forms of the vaccine developed by the Moscow-based Gamaleya research institute—liquid and powder for injections—will be tested on two groups of volunteers, 38 people each, the statement said. The participants will be isolated in two Moscow hospitals. “Running clinical trials in the […]

Read more

Promising pre-clinical results for COVID-19 vaccine

A COVID-19 vaccine candidate developed by the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has cleared another major milestone in moving towards human clinical trials: the novel vaccine has proven highly effective in ferrets, one of the commonly used animal models for COVID-19. To evaluate the effectiveness of the vaccine, the ferrets received two immunizations […]

Read more

Coronavirus vaccine: U.S. company trials vaccine candidate in Australia

CANBERRA, Australia — A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday with hopes of releasing a proven vaccine this year. Novavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and looking for signs of its effectiveness, the company’s research chief Dr. Gregory Glenn […]

Read more

First clinical trial with genetically modified malaria vaccine completed

In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection. Malaria is a major infectious disease, caused by a parasite with a complicated life cycle […]

Read more

COVID-19 vaccine updates: Hunt heats up globally, still no guarantee

WASHINGTON — Hundreds of people are rolling up their sleeves in countries across the world to be injected with experimental vaccines that might stop COVID-19, spurring hope — maybe unrealistic — that an end to the pandemic may arrive sooner than anticipated. About 100 research groups are pursuing vaccines with nearly a dozen in early stages of human trials or […]

Read more
1 2 3 4